agents investigational receiving patients subjects ineligible patient treatment days registration 
current use malignancy treatment history diagnosis study disease planned prior 
agents investigational weeks use study treatment days prior current receiving 
statin use current therapy donor pbsc months treatment drugs pravastatin 
concurrently investigational receiving agents study patients drug days treatment participation 
medication immunosuppressive prior use current days dose systemic treatment exceptions 
